Search
for
Sort by
Research 391–420 of 1000+
- Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo
- Androgen receptor-mediated gene activation in prostate cancer cells
- STEROID HORMONES IN GERIATRICS
- Reversal of Advanced Androgenetic Alopecia Through Individualized Classical Homeopathy & Exosomes Therapy at Dr Batra’s® Homeopathy Clinic
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models
- African Journal of Biomedical Research
- The manosphere and men's health: unpacking the links between online communities, body dysmorphia and erectile dysfunction
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- Microalgae, <i>Tetraselmis tetrathele</i> has Alopecia Prevention and Scalp Improvement
- Morphological Changes of Meibomian Glands in Men With Benign Prostate Hyperplasia
- Dermatology in the Black barbershop: A potential opportunity for expanding access and bridging gaps
- Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens
- Steroidogenesis in steroid related cancers
- Incidence of alopecia from endocrine therapies in cancer
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Onychomatricoma with classic features: Case report and review of the literature
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- S90 Urethral PSA production after radical prostatectomy
- DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- Bioavailability File: Bicalutamide
- In Search of Predictive Models for Inhibitors of 5-alpha Reductase 2 Based on the Integration of Bioactivity and Molecular Descriptors Data.
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health